Sequoia Financial Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,120
Closed -$1.13M 1974
2025
Q4
$1.13M Buy
11,120
+1,895
+21% +$152K 0.01% 824
2025
Q3
$505K Buy
9,225
+833
+10% +$41.6K ﹤0.01% 1131
2025
Q2
$446K Buy
8,392
+103
+1% +$5.23K ﹤0.01% 1060
2025
Q1
$359K Sell
8,289
-187
-2% -$9.47K ﹤0.01% 995
2024
Q4
$476K Buy
8,476
+116
+1% +$7.22K ﹤0.01% 824
2024
Q3
$569K Buy
+8,360
New +$472K 0.01% 704
2024
Q1
Sell
-6,980
Closed -$516K 1213
2023
Q4
$516K Buy
+6,980
New +$458K 0.01% 719

Other funds holding EXAS

Sequoia Financial Advisors's EXAS Position: Q1 2026 in Review

Sequoia Financial Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11,120 shares — an estimated $1.13M sold.

Sequoia Financial Advisors first reported a position in EXAS in Q4 2023 and held it in 7 quarters. The position peaked at $1.13M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Sequoia Financial Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Sequoia Financial Advisors sold 11,120 Exact Sciences shares in Q1 2026, an estimated $1.13M.
  • Sequoia Financial Advisors first reported a position in Exact Sciences in Q4 2023 and held it in 7 quarters.
  • Sequoia Financial Advisors's Exact Sciences position peaked at $1.13M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sequoia Financial Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.